Studies in osteoclast cultures showed that selective pharmacological inhibition of IKKβ inhibited both breast cancer- and RANKL-induced osteoclast formation and caused osteoclast apoptosis in mature osteoclast cultures. Here, IKBKB is linked to breast cancer.